Shopping Cart


Your shopping bag is empty

Go to the shop

ZeniFOAM Ag GENTLE BORDER is a sterile, silicone-faced, silver polyurethane foam dressing with a silicone adhesive border designed to absorb moderate to heavy wound drainage. ZeniFOAM Ag GENTLE BORDER contains 0.25-0.35mg/cm3 of silver ions and has been shown to have antibacterial effectiveness for up to 7 days, as demonstrated in vitro. ZeniFOAM Ag GENTLE BORDER is a multi-layered dressing that provides maximum absorption while protecting sensitive or fragile skin and reducing painful dressing changes.  

Sold as each, not per box

  • Moderately to Heavily Draining Wounds

  • Pressure Ulcers

  • Superficial Burns

  • Leg Ulcers

  • Foot Ulcers

  • Traumatic Wounds

  • Partial Thickness Burns

  • Lacerations

  • Abrasions

  • Surgical Wounds

  • Do not use as an internal dressing/sponge.

  • Do not use on third-degree burns.

  • Do not use if a known allergy or hypersensitivity exists silver.


ZeniFOAM Ag GENTLE BORDER requires a prescription for use from a medical provider.

ZeniFOAM Ag GENTLE BORDER is single use only. Do not reuse.

Do not use if the pouch is damaged or opened.

Not recommended for use on dry wounds.

Do not use ZeniFOAM Ag GENTLE BORDER with oxidizing agents such as hypochlorite solutions or hydrogen peroxide.

ZeniFOAM Ag GENTLE BORDER may cause transient discoloration of the wound bed and surrounding skin. Frequent or prolonged use may result in permanent discoloration of the skin.

ZeniFOAM Ag GENTLE BORDER does not replace the need for systemic therapy or other adequate infection treatment in the event of clinical infection.

Do not use during radiation treatment or examinations such as x-ray, magnetic resonance imaging (MRI) or ultrasound.

Avoid contact with EKG electrodes or conducive gels during electronic measurements such as electrocardiograms (ECG) and electroencephalogram (EEG).

ZeniFOAM Ag GENTLE BORDER is intended for short term use up to 28 days.

Reduction in colonization or microbial growth on the device has not been shown to correlate with a reduction in infections in patients.